Double maintains 1 strategies that include FDMT - 4D Molecular Therapeutics, Inc.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -33.14% | $295.67M | 1.43% |
VIXY | -30.48% | $165.58M | 0.85% |
TAIL | -26.61% | $99.49M | 0.59% |
IVOL | -15.10% | $348.25M | 1.02% |
STPZ | -11.86% | $450.05M | 0.2% |
TPMN | -10.42% | $30.70M | 0.65% |
TBLL | -9.08% | $2.13B | 0.08% |
XONE | -8.91% | $585.85M | 0.03% |
VTIP | -7.84% | $15.34B | 0.03% |
STIP | -7.54% | $12.70B | 0.03% |
TDTT | -7.50% | $2.63B | 0.18% |
UTWO | -7.18% | $379.27M | 0.15% |
SPTS | -7.15% | $5.77B | 0.03% |
CARY | -6.99% | $347.36M | 0.8% |
KCCA | -6.77% | $105.90M | 0.87% |
AGZD | -6.60% | $102.60M | 0.23% |
CLIP | -6.04% | $1.51B | 0.07% |
SCHO | -5.40% | $11.46B | 0.03% |
IBTF | -5.11% | $2.02B | 0.07% |
ULST | -4.74% | $658.54M | 0.2% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RGNX | 44.07% | $414.70M | -23.44% | 0.00% |
STOK | 43.48% | $636.05M | -9.20% | 0.00% |
IDYA | 43.29% | $1.85B | -37.37% | 0.00% |
BEAM | 42.78% | $1.76B | -22.33% | 0.00% |
IMNM | 42.32% | $736.56M | -27.65% | 0.00% |
DNLI | 42.11% | $2.03B | -35.83% | 0.00% |
CLDX | 41.96% | $1.41B | -42.69% | 0.00% |
NRIX | 41.20% | $892.72M | -38.14% | 0.00% |
APGE | 40.84% | $2.63B | +15.83% | 0.00% |
ARCT | 40.71% | $352.30M | -39.53% | 0.00% |
CRSP | 40.27% | $4.19B | -8.67% | 0.00% |
CMPS | 40.05% | $293.40M | -46.98% | 0.00% |
KRO | 39.85% | $739.68M | -49.05% | 3.08% |
NNOX | 39.54% | $326.14M | -25.33% | 0.00% |
COGT | 38.95% | $822.04M | -12.38% | 0.00% |
ATXS | 38.86% | $306.44M | -39.46% | 0.00% |
EYPT | 38.79% | $657.15M | +19.23% | 0.00% |
OCUL | 38.77% | $1.45B | +36.23% | 0.00% |
AEO | 38.57% | $1.77B | -47.37% | 4.91% |
AUTL | 38.47% | $609.46M | -32.25% | 0.00% |
Finnhub
4FRONT-1 Phase 3 expected data readout accelerated from H2 2027 to H1 20274FRONT-2 Phase 3 trial initiated ahead of schedule Streamlined late-stage clinical and pre-commercial organization aligns with...
Finnhub
4D Molecular Therapeutics, Inc. dropped from Russell Microcap Growth Index...
Finnhub
4D Molecular Therapeutics, Inc. dropped from Russell 3000E Growth Index...
Finnhub
4D Molecular Therapeutics, Inc. dropped from Russell 2500 Growth Index...
Finnhub
4D Molecular Therapeutics, Inc. dropped from Russell 3000 Growth Index...
Finnhub
4D Molecular Therapeutics, Inc. dropped from Russell Small Cap Comp Growth Index...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CARM | 0.01% | $16.92M | -71.88% | 0.00% |
PEP | 0.10% | $185.45B | -17.31% | 4.04% |
ALL | 0.10% | $53.00B | +24.95% | 1.94% |
FTS | -0.11% | $23.99B | +23.37% | 3.67% |
ARDT | -0.13% | $1.96B | -14.19% | 0.00% |
DRD | 0.15% | $1.15B | +55.76% | 2.05% |
EGO | 0.17% | $4.18B | +37.38% | 0.00% |
UVV | -0.17% | $1.42B | +20.13% | 5.63% |
CACI | -0.21% | $10.63B | +12.88% | 0.00% |
CHD | -0.23% | $24.05B | -7.40% | 1.18% |
MNOV | -0.24% | $62.29M | -9.29% | 0.00% |
HSY | 0.31% | $35.62B | -4.79% | 3.11% |
AGL | 0.36% | $985.21M | -59.52% | 0.00% |
AMR | -0.38% | $1.37B | -67.82% | 0.00% |
MDLZ | 0.43% | $89.29B | +4.44% | 2.72% |
UNH | -0.43% | $295.85B | -34.54% | 2.69% |
DUK | -0.50% | $92.39B | +19.10% | 3.55% |
UL | -0.53% | $150.91B | +12.15% | 3.19% |
PINC | 0.56% | $1.79B | +17.43% | 3.92% |
CVS | 0.56% | $88.02B | +20.97% | 3.92% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GNOM | 49.46% | $44.38M | 0.5% |
XBI | 48.64% | $4.84B | 0.35% |
IBB | 45.16% | $5.28B | 0.45% |
ARKG | 45.14% | $1.02B | 0.75% |
IWC | 43.77% | $817.74M | 0.6% |
BBH | 40.42% | $329.37M | 0.35% |
PBE | 40.19% | $223.86M | 0.58% |
IWO | 39.92% | $11.53B | 0.24% |
PTH | 39.43% | $100.70M | 0.6% |
HYDR | 38.94% | $32.24M | 0.5% |
PBW | 38.80% | $268.39M | 0.65% |
CWB | 38.77% | $3.86B | 0.4% |
IWM | 38.75% | $63.18B | 0.19% |
VTWO | 38.74% | $12.58B | 0.07% |
KOMP | 38.21% | $2.28B | 0.2% |
SCHA | 38.06% | $17.26B | 0.04% |
NUSC | 38.00% | $1.14B | 0.31% |
KJUL | 37.66% | $119.28M | 0.79% |
ICVT | 37.41% | $2.52B | 0.2% |
PINK | 37.41% | $129.96M | 0.5% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBIL | 0.01% | $783.84M | 0.15% |
SCHR | -0.03% | $11.10B | 0.03% |
FXC | -0.08% | $93.05M | 0.4% |
SPTI | -0.08% | $8.80B | 0.03% |
IBTK | 0.09% | $441.97M | 0.07% |
SGOL | -0.10% | $5.14B | 0.17% |
VGIT | -0.12% | $31.79B | 0.04% |
GLDM | -0.13% | $15.61B | 0.1% |
USFR | -0.16% | $18.59B | 0.15% |
BILZ | 0.18% | $827.73M | 0.14% |
OUNZ | -0.24% | $1.74B | 0.25% |
GLD | -0.26% | $100.17B | 0.4% |
JUCY | 0.32% | $269.60M | 0.6% |
AAAU | -0.33% | $1.54B | 0.18% |
USL | 0.36% | $42.30M | 0.85% |
IAU | -0.42% | $46.48B | 0.25% |
IBTL | 0.45% | $379.97M | 0.07% |
BNO | -0.46% | $103.86M | 1% |
USO | -0.48% | $1.22B | 0.6% |
BSV | -0.49% | $38.37B | 0.03% |
Current Value
$4.151 Year Return
Current Value
$4.151 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -20.58% | $24.29B | +35.36% | 1.09% |
K | -12.47% | $27.71B | +40.85% | 2.85% |
VZ | -10.24% | $184.17B | +6.28% | 6.15% |
CME | -9.83% | $99.25B | +39.75% | 3.87% |
NOC | -9.77% | $72.47B | +15.13% | 1.72% |
MO | -9.69% | $97.93B | +26.25% | 6.95% |
PGR | -8.90% | $154.94B | +25.19% | 1.87% |
HUSA | -8.57% | $21.26M | -8.69% | 0.00% |
GIS | -8.46% | $28.85B | -15.80% | 4.51% |
KO | -8.33% | $308.49B | +13.49% | 2.78% |
ALHC | -7.82% | $2.81B | +80.33% | 0.00% |
VHC | -7.56% | $48.79M | +87.46% | 0.00% |
KR | -7.54% | $47.17B | +41.48% | 1.81% |
EXC | -6.94% | $43.82B | +25.72% | 3.63% |
GO | -6.50% | $1.27B | -41.23% | 0.00% |
CABO | -6.40% | $795.04M | -59.44% | 6.27% |
ED | -6.39% | $36.31B | +13.27% | 3.35% |
LITB | -6.24% | $22.07M | -77.41% | 0.00% |
CAG | -5.92% | $10.05B | -25.70% | 6.63% |
ACI | -5.69% | $12.20B | +8.96% | 2.48% |